On August 31, 2026, DFZQ bought 30,800 shares of SKB BIO (06990) stock at an average of HKD 492.9088 per share, involving about HKD 15.18 million.
Prior to the acquisition, DFZQ's long position in SKB BIO was 8.84 million shares, representing 4.99%; following the acquisition, the holding changed to 8.87 million shares, with the long position ratio rising to 5.01%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.